Skip to main content
Skip to footer


Dr Swadha Anand

Senior Scientist, Life Sciences


  • Microneedle-assisted transdermal drug delivery requires minimal training for use and enables painless insertion with no side effects. 
  • While production-scale manufacturing facilities are only available for microneedle array patch (MAP), used in cosmetics; preclinical and clinical research is being conducted on MAPs to also administer drugs and vaccines. 
  • The most used route of insulin administration among diabetic patients has several demerits and poses a serious clinical challenge to the pediatric population. Therefore, scientists have been trying to develop microneedle-based, minimally invasive or non-invasive insulin delivery methods.